Evolent Health (EVH) Other financing activities (2015 - 2020)

Evolent Health has reported Other financing activities for 6 years, with the latest figure at $33.7 million in Q1 2020.

• For the quarter ending Q1 2020, Other financing activities rose 5439.14% year-over-year to $33.7 million; the trailing twelve-month figure through Mar 2020 stood at -$71.2 million (down 159.82% YoY), and the FY2019 full-year result was -$104.3 million, down 208.44% from the prior year.
• Other financing activities for Q1 2020 stood at $33.7 million, up from -$104.9 million in the prior quarter.
• The five-year high for Other financing activities was $120.1 million in Q3 2019, with the low at -$120.1 million in Q2 2019.
• Average Other financing activities over 5 years is $2.1 million, with a median of $1.1 million recorded in 2016.
• Year-over-year, Other financing activities plunged 639.4% in 2019 and jumped 5439.14% in 2020.
• Tracing EVH's Other financing activities over 5 years: stood at $1.6 million in 2016, then jumped by 1240.5% to $21.4 million in 2017, then jumped by 348.31% to $96.2 million in 2018, then tumbled by 209.07% to -$104.9 million in 2019, then surged by 132.11% to $33.7 million in 2020.
• The last three Other financing activities figures came in at $33.7 million (Q1 2020), -$104.9 million (Q4 2019), and $120.1 million (Q3 2019), per Business Quant data.

Peer Comparison